Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|May 31, 2023
Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort studyMax J Rieger, Xenia Schenkel, Ivona Dedic, et al.
Cancers|March 28, 2024
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid TumorsFilip Janku, Grace M Choong, Mateusz Opyrchal, et al.
Neoplasia (New York, N.Y.)|November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer centerJens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
Microsystems & Nanoengineering|December 23, 2022
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsiesFabienne D Schwab, Manuel C Scheidmann, Lauren L Ozimski, et al.
Journal of Geriatric Oncology|December 19, 2018
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10Dirk L Kienle, Daniel Dietrich, Karin Ribi, et al.
The Lancet Regional Health. Europe|May 25, 2026
Efficacy and Safety Evidence Supporting Cancer Drug Approvals in Switzerland (2001-2020): A Meta-Analysis of Pivotal Randomised Controlled TrialsParisa Rahimzadeh, Qiyu Li, Leonie Rudofsky, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Oncoimmunology|May 5, 2020
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapyCyrill A Rentsch, Piet Bosshard, Grégoire Mayor, et al.
Clinical Colorectal Cancer|November 13, 2024
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16Sara Bastian, Markus Joerger, Lisa Holer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2018
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)Andreas Wicki, Nicholas Brown, Alexandros Xyrafas, et al.
Pageof 9